Open Nav

Edward Painter


A2A Pharmaceuticals

Edward Painter is the founder and CEO of A2A Pharmaceuticals Inc. At A2A, the mission is to leverage proprietary computational systems, including A.I., to accelerate development of novel drug alternatives for life threatening diseases like cancer, bacterial infections and muscular dystrophy.

Mr. Painter’s experience includes over 25 years investing in and helping life sciences as well as other technology companies raise capital with firms like Goldman Sachs and UBS.

This speaker's sessions: